Innovative research indicates that Retatrutide, specifically the 40mg dosage , could provide a promising advance in the approach of excess weight . Distinct from many existing therapies, Retatrutide works as a double GIP and GLP-1 agent agonist, potentially leading to greater weight loss and relate